Altered dynamic functional connectivity in antagonistic state in first-episode, drug-naïve patients with major depressive disorder
Year: 2024
Type: article
Study design: Observational Study
Abstract: OBJECTIVE: Major depressive disorder (MDD) is known to be characterized by disrupted brain functional network connectivity (FNC) patterns, while the dynamic change mode of different functional networks is unclear. This study aimed to characterize specific dynamic alterations pattern on intrinsic FNC in MDD by combining static FNC (sFNC) and dynamic FNC (dFNC). METHODS: A total of 48 first-episode drug-naïve MDD and 48 matched healthy controls (HCs) were included in this study. The sFNC and dFNC were analyzed using complete time-series and sliding window approach, respectively. Both sFNC and dFNC differences between groups were analyzed and associations between disease severity and aberrant FNC were explored. RESULTS: MDD patients exhibited lower sFNC within and between sensory and motor networks than HC. Four dFNC states were identified, including a globally-weakly-connected state, a cognitive-control-dominated state, a globally-positively-connected state, and an antagonistic state. The antagonistic state was marked by strong positive connections within the sensorimotor domain and their anti-correlations with the executive-motor control domain. Notably, MDD patients exhibited significantly longer dwell time in the globally-weakly-connected state, at the cost of significantly shorter dwell time in the antagonistic state. Further, only the mean dwell time of this antagonistic state was significantly anticorrelated to disease severity measures. CONCLUSIONS: Our study highlights the altered dynamics of the antagonistic state as a fundamental aspect of disrupted FNC in early MDD.
Source: BMC Psychiatry
Authors: Min Wang, Tao Chen, Zhongyi He, Lawrence Wing-Chi Chan, Qinger Guo, Shuyang Cai, Jingfeng Duan, Danbin Zhang, Xunda Wang, Yu Fang, Hong Yang
Language: English
Subfield: Cognitive Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,190
Awards: G1548073425, G1854712095, G7367216347
OpenAlex ID: W4405543698
